Panorama Research Inc. (PRI) is a privately owned biomedical research and development holding company. PRI effectively serves as an incubator of a number of technologies and pharmaceutical projects that subsequently were licensed to development partners or incorporated into PRI portfolio companies. The firm has spun out a large number of small firms of which some have gone to an IPO. 26 firms are listed as incorporated into PRI portfolio of companies of which 9 are/have been SBIR involved in their own right. The core expertise of PRI includes medicinal and organic chemistry, pharmacology, molecular and cell biology, plant molecular biology, oncology, immunology, infectious diseases and medicine.
